Innoviva (INVA) EBT Margin (2011 - 2026)
Innoviva (INVA) posted EBT Margin of -90.32% for Q2 2026, down 162.72 percentage points from 72.39% a year earlier and down 329.69 percentage points from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) EBT Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Innoviva was 95.32%, up 77.61 percentage points year-over-year; for FY2025, it came in at 79.47%, up 69.04 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of -25.72 percentage points (FY2020 to FY2025).
- In prior years, Innoviva's EBT Margin was 10.42% in FY2024 (-52.10 pp), 62.52% in FY2023 (-24.08 pp), 86.60% in FY2022 (-27.03 pp) and 113.63% in FY2021 (+8.45 pp).
- The Q2 2026 figure stands as the lowest quarterly EBT Margin since Q1 2015.
- On a year-over-year basis, EBT Margin increased in four of the last six quarters, with an average year-over-year change of +59.42 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q1 2026, with a gain of 282.90 percentage points; the weakest was Q4 2023, with a drop of 298.07 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 239.36% (Q1 2026), 170.17% (Q4 2025) and 90.74% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | -90.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.32% |
| Mar 31, 2026 | 239.36% |
| Dec 31, 2025 | 170.17% |
| Sep 30, 2025 | 90.74% |
| Jun 30, 2025 | 72.39% |
| Mar 31, 2025 | -43.54% |
| Dec 31, 2024 | 26.90% |
| Sep 30, 2024 | 7.65% |
| Jun 30, 2024 | -39.32% |
| Mar 31, 2024 | 58.23% |
| Sep 30, 2023 | 127.79% |
| Jun 30, 2023 | 7.17% |
| Mar 31, 2023 | 53.87% |
| Sep 30, 2022 | 425.86% |
| Jun 30, 2022 | 18.94% |
| Mar 31, 2022 | 49.65% |
| Dec 31, 2021 | 52.46% |
| Sep 30, 2021 | 125.87% |
| Jun 30, 2021 | 135.09% |
| Mar 31, 2021 | 151.35% |
API Access
Innoviva EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();